BCL2L1 and arthritic joint disease: Mice receiving FoxP3-plus-Bcl-xL-transduced Tregs had a significantly decreased incidence of arthritis compared with mice receiving Tregs transduced with FoxP3 alone (32% versus 70% on day 60; Figure 5a).